The ASCENT project is collaborating with City Health, and TB HIV Care funded by the Global Fund to implement Digital Adherence Technologies (DATs), to support tuberculosis (TB) patients to successfully complete their treatment in the Western Cape.
ASCENT Ethiopia conducted a one-day review meeting in Bishoftu town Gold Mark Hotel for better implementation of the project.
During a recent virtual meeting, key tuberculosis (TB) partners jointly reviewed and updated the ASCENT differentiated care pathway for the use of digital adherence technologies (DAT) to support TB patients taking their medication.
Devex interview about digital adherence technologies: “We hope that our research will contribute to the WHO policy”
Over the years, digital technologies have been introduced to improve patients’ adherence to tuberculosis (TB) treatment, but with little research showing how feasible these technologies are.
Research begins into new digital tools to support patients and healthcare workers through tuberculosis treatment
A large global study which aims to determine if digital adherence technologies can provide more patient-friendly approaches to improve tuberculosis (TB) treatment outcomes launches in Ethiopia, Tanzania, South Africa, the Philippines and Ukraine, as part of the ASCENT project.
As the main research phase of the innovative ASCENT project kicks off, we asked the main researchers Jens Levy, Katherine Fielding and Amare Tadesse to elaborate on the study. Why are they so determined to generate scientific evidence on the use of digital adherence technologies for tuberculosis (TB) treatment?
Mehamed is a father of one daughter, husband and merchant of used clothes. He lives in Addis Ababa (Ethiopia) and was diagnosed with tuberculosis (TB) at the age of 27. Shortly after his diagnosis, he started his treatment supported by a smart pillbox provided by the ASCENT project, funded by Unitaid and led by KNCV Tuberculosis Foundation.
Today is World Tuberculosis Day. This year’s theme, ‘The Clock is Ticking’, tells us that the world is running out of time to act on the commitments to end tuberculosis (TB), especially now that the COVID-19 pandemic is hampering the progress of the ongoing actions.
The ASCENT South Africa team recently held a successful randomization event which also served as the kick-off of the digital adherence technologies (DAT) project in South Africa.